About Serigen
Serigen is a company based in Pune (India) founded in 2015 by Swati Shukla, Anuya Nisal, and Premnath Venugopalan. Serigen has raised $2.33 million across 4 funding rounds from investors including BioAngels, Sparrow Technologies and Indian Angel Network. Serigen offers products and services including Serioss, Seriderm, and Serimat. Serigen operates in a competitive market with competitors including MiMedx Group, Ossio, Theradaptive, EpiBone and Biocomposites, among others.
- Headquarter Pune, India
- Founders Swati Shukla, Anuya Nisal, Premnath Venugopalan
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Serigen Mediproducts Private Limited
- Date of Incorporation 03 Feb, 2015
- Jurisdiction Pune City, Maharashtra, India
-
Annual Revenue
$15.89 K (USD)126.46as on Mar 31, 2022
-
Net Profit
-$131.46 K (USD)-7.08as on Mar 31, 2022
-
EBITDA
-$138.29 K (USD)-9.94as on Mar 31, 2022
-
Total Equity Funding
$2.33 M (USD)
in 4 rounds
-
Latest Funding Round
$1.19 M (USD), Seed
Aug 30, 2024
-
Investors
BioAngels
& 46 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Serigen
Serigen offers a comprehensive portfolio of products and services, including Serioss, Seriderm, and Serimat.
Osteoconductive filler for bone cavities caused by trauma or infection.
Absorbent dressing that accelerates healing of diabetic ulcers and burns.
Engineered matrix for promoting regeneration of soft tissues.
Funding Insights of Serigen
Serigen has successfully raised a total of $2.33M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.19 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Serigen
Serigen has secured backing from 47 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include BioAngels, Sparrow Technologies and Indian Angel Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel investor network investing in early-stage startups
|
Locked | Locked | Locked | |
|
Investments are directed by Colossa Ventures toward diverse tech sectors.
|
Locked | Locked | Locked | |
|
Investment and support platform for biotech and related startups in India.
|
Locked | Locked | Locked |
Investor details for Serigen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Serigen
Investment portfolio details for Serigen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Serigen
Detailed financials for Serigen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Serigen Comparisons
Peer comparison for Serigen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Serigen
Serigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Ossio, Theradaptive, EpiBone and Biocomposites, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
|
| Locked | Locked | Locked |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| Locked | Locked | Locked |
Implants for bone and cartilage regeneration are developed and provided.
|
Detailed competitors of Serigen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Serigen
Complete news archive for Serigen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Serigen
Serigen was founded in 2015 and raised its 1st funding round 5 years after it was founded.
Serigen is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Anuya Nisal is the current CEO of Serigen. They have also founded this company.
Serigen is a funded company, having raised a total of $2.33M across 4 funding rounds to date.
Annual revenue of Serigen is $15.89K as on Mar 31, 2022.
Developer of protein-based tissue regeneration products for orthopedics. It uses natural silk proteins to develop tissue regeneration products such as Serioss for bone tissue repair, Serimat for soft tissue regeneration, and Seriderm for wound healing.
Serigen's top competitors include EpiBone, Theradaptive and MiMedx Group.
Serigen offers Serioss, Seriderm, and Serimat.
Serigen has 47 investors. Key investors include BioAngels, Sparrow Technologies, Indian Angel Network, Colossa Ventures, and Shantanu Deshpande.
The valuation of Serigen is $7.86M as of Mar 2023.